The Cost of Exclusion in Psychedelic Research
The lack of diversity among research participants can have significant consequences on generalizability and distribution of treatments.

The lack of diversity among research participants can have significant consequences on generalizability and distribution of treatments.

The field has a frustrating tendency to make lofty claims about psychedelics that stray from the realities and limitations of the data.

As a scholar of religion who cares deeply about this psychedelic renaissance, I offer two points of caution from the perspective of my field.

Amid a fractured political landscape, a pandemic, and a reckoning with the country’s racist past, psychedelics may offer some hope for healing.

While city-wide decriminalization efforts make psilocybin a “low priority” for law enforcement, state and federal agencies provide no such guarantees.

A focus on furthering neurodiversity could allow the psychedelics decriminalization movement to gain broader public support.

By Yusuf Lenfest I thought I would take this opportunity to reflect on the past year, where I will be in the future, and how the student fellowship has impacted me. I still hope to contribute to the Bill of Health blog going forward, but as my last official post as a Petrie-Flom Student Fellow,…